Incomplete asset inventories, expensive licence models and no visibility of asset performance per batch. Many pharmaceutical companies still struggle with siloed or fragmented systems that lack an integrated overview. With holistic asset management, organisations can move from reactive firefighting to proactive control and predictable maintenance.

The problem with siloed systems

System fragmentation may sound abstract, but it has very real operational consequences. Many pharma companies use asset management systems, yet these are often outdated, costly in licences, or not interconnected.

Without integrated data, it is impossible to see how assets behave across different batches or which components are consistently under higher load. The result is limited insight into the true condition of equipment, a higher risk of unplanned downtime, and reduced control over the total lifecycle.

Holistic asset management: complete transparency

By linking asset data to production processes, companies gain full insight into the load, performance, and lifecycle of their equipment. This makes maintenance and replacement predictable rather than reactive.

The approach starts with a complete inventory of all assets, including unregistered components, followed by data integration and visualisation through AI-driven dashboards for lifecycle management.

Holistic asset management enables:

  • A complete overview of all assets and their interdependencies
  • Predictive maintenance based on actual usage data
  • Integrated planning of firmware upgrades and replacements
  • Risk reduction through timely action on lifecycle information
  • Cost savings through more efficient use of resources
  • Improved compliance thanks to full traceability and audit trails (GMP/GxP)
     

Organon Pharma: from reactive to proactive

At Organon Pharma, a global producer of medicines focused on women’s health, the implementation of holistic asset management led to a fundamental shift in operations.

ICT Group developed AI-based dashboards for lifecycle management, enabling predictive maintenance planning. Lifecycle management is now fully integrated into daily operations, with cybersecurity and data integrity embedded by design.
The transition from reactive to proactive asset management has resulted in higher reliability, fewer breakdowns, and a more balanced production environment.

Read more here

From data to insight to action

The real breakthrough lies in connecting asset performance to the production context. Instead of only knowing that a pump is running, manufacturers can now see how heavily it is loaded under different recipes.

Maintenance is scheduled based on actual wear rather than fixed intervals. This approach reduces unplanned downtime, lowers maintenance costs, extends the lifetime of critical equipment, and strengthens compliance through up-to-date documentation.

Laying the foundation for future growth

Pharma companies that invest in holistic asset management are building the foundation for predictable, safe, and efficient production.

By combining real-time insights with predictive maintenance, a new standard in operational excellence emerges where asset data, cybersecurity and lifecycle management converge in one integrated approach.

Interested in how ICT Group can support your pharmaceutical organisation with holistic asset management?

Contact our experts
Michel van Heumen

Michel van Heumen

Sr. Business Development Manager
Edward

Edward van Katwijk

Business Development Executive
+31 (0)6 42 33 67 10